GCG, glucagon, 2641

N. diseases: 441; N. variants: 10
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C1855520
Disease: Hyperglycemia, Postprandial
Hyperglycemia, Postprandial
0.300 Therapeutic phenotype CTD_human The glucagon-like peptide-1 receptor agonist oxyntomodulin enhances beta-cell function but does not inhibit gastric emptying in mice. 18669601 2008
CUI: C1855520
Disease: Hyperglycemia, Postprandial
Hyperglycemia, Postprandial
0.300 Biomarker phenotype CTD_human The glucagon-like peptide-1 receptor agonist oxyntomodulin enhances beta-cell function but does not inhibit gastric emptying in mice. 18669601 2008
CUI: C1855520
Disease: Hyperglycemia, Postprandial
Hyperglycemia, Postprandial
0.300 Biomarker phenotype CTD_human Beta-adrenergic contribution to glucagon-induced glucose production and insulin secretion in uremia. 3019152 1986
CUI: C1855520
Disease: Hyperglycemia, Postprandial
Hyperglycemia, Postprandial
0.300 Therapeutic phenotype CTD_human Beta-adrenergic contribution to glucagon-induced glucose production and insulin secretion in uremia. 3019152 1986